A
Allied Corp
OTC:ALID
Allied Corp
OTC:ALID
Price:
0.0005
USD
Market Closed
Market Cap:
$115.5
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX
|
US |
|
S
|
Shoprite Holdings Ltd
JSE:SHP
|
ZA |
|
Netscientific PLC
LSE:NSCI
|
UK |
Allied Corp
Non-Reccuring Items
Last
Value
3 Years
3Y
CAGR
5 Years
5Y
CAGR
10 Years
10Y
CAGR
|
See Also
Allied Corp
Non-Reccuring Items Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Non-Reccuring Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Allied Corp
OTC:ALID
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bausch Health Companies Inc
TSX:BHC
|
Non-Reccuring Items
-$210m
|
CAGR 3-Years
-51%
|
CAGR 5-Years
21%
|
CAGR 10-Years
11%
|
|
|
Canopy Growth Corp
TSX:WEED
|
Non-Reccuring Items
-CA$32.7m
|
CAGR 3-Years
75%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
|
Cronos Group Inc
TSX:CRON
|
Non-Reccuring Items
-$2.8m
|
CAGR 3-Years
66%
|
CAGR 5-Years
44%
|
CAGR 10-Years
-9%
|
|
|
Mind Medicine (MindMed) Inc
NASDAQ:MNMD
|
Non-Reccuring Items
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Non-Reccuring Items
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
No Stocks Found
Allied Corp
Glance View
Allied Corp. operates as a medical cannabis company. The company is headquartered in Kelowna, British Columbia. The company went IPO on 2018-12-04. The firm is focused on creating and providing health solutions to address medical mental health issues. The firm focuses to discover medical technologies, which are cannabis derived to target full scope therapy and support for trauma survivors, military veterans and first responders. Its functional mushroom formulation targets major depression and anxiety. The firm is also engaged in research and development activities in the psilocybin space and holds formulations.
ALID
Intrinsic Value
Not Available
A
